Suppr超能文献

IVsight作为接受静脉治疗患者的输液监测器:一项探索性、非盲法、单中心试验。

IVsight as an Infusion Monitor for Patients Receiving Intravenous Therapy: An Exploratory, Unblinded, Single-Center Trial.

作者信息

Mejia-Chew Carlos, Heuring Brett, Salmons Jeffrey, Weilmuenster Lori, Beggs Joe, Kleinschmidt Glen, Eshelman Jake, Dodda Sai

机构信息

Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri.

BJC Home Care Services, St. Louis, Missouri.

出版信息

Curr Ther Res Clin Exp. 2024 Apr 1;100:100747. doi: 10.1016/j.curtheres.2024.100747. eCollection 2024.

Abstract

BACKGROUND

Intravenous (IV) infusion therapy is commonly used in health care settings. However, IV therapy at home can be challenging because it relies on the patient's ability to manage multiple medications correctly, which may lead to decreased treatment adherence.

OBJECTIVE

We aimed to assess the usability and accuracy of the IVsight monitor in capturing IV infusion data compared to manual recording.

METHODS

A prospective, single-center, usability study involving patients receiving IV infusion therapy at one of the BJC's Home Infusion suites was conducted to evaluate the accuracy, performance, and acceptability of the device IVsight as a monitor for IV infusions.

RESULTS

Of the 15 participants, the median (IQR) age was 46 years (36-55), 8 (53%) were female, and 13 (87%) were non-Hispanic white. Each participant received a median (IQR) of 4 (4-5) infusions during the study, and 68 infusions were observed overall. The intraclass correlation coefficient between the IVsight measurement and manual recording of infusion duration in seconds was excellent (ICC 0.97, 95% confidence interval 0.96-0.98). The Bland-Altman plot visually showed an acceptable limit of agreement for the 2 measurements, and the linear regression analysis revealed no significant proportional bias between the 2 methods for measuring the IV infusion time. None of the participants thought that IVsight was difficult to hold, use, clean, or store. Only one participant was concerned that the device could interfere with the IV infusion, and all participants felt comfortable with the device transmitting data to their health care providers.

CONCLUSIONS

The IVsight infusion monitoring device showed near-perfect agreement on the recorded IV infusion duration compared with manual recording, and good acceptability among the study participants.

摘要

背景

静脉输注疗法在医疗环境中常用。然而,家庭静脉治疗具有挑战性,因为它依赖患者正确管理多种药物的能力,这可能导致治疗依从性降低。

目的

我们旨在评估与手动记录相比,IVsight监测仪在获取静脉输注数据方面的可用性和准确性。

方法

进行了一项前瞻性、单中心的可用性研究,纳入在BJC家庭输液套房之一接受静脉输注治疗的患者,以评估IVsight设备作为静脉输注监测仪的准确性、性能和可接受性。

结果

15名参与者中,年龄中位数(四分位间距)为46岁(36 - 55岁),8名(53%)为女性,13名(87%)为非西班牙裔白人。每位参与者在研究期间接受的输注次数中位数(四分位间距)为4次(4 - 5次),共观察到68次输注。IVsight测量与以秒为单位的手动记录的输注持续时间之间的组内相关系数极佳(ICC 0.97,95%置信区间0.96 - 0.98)。Bland - Altman图直观显示两种测量方法的一致性界限可接受,线性回归分析表明两种测量静脉输注时间的方法之间无显著比例偏差。没有参与者认为IVsight难以握持、使用、清洁或储存。只有一名参与者担心该设备会干扰静脉输注,所有参与者对设备向其医疗服务提供者传输数据感到放心。

结论

与手动记录相比,IVsight输液监测设备在记录的静脉输注持续时间上显示出近乎完美的一致性,且在研究参与者中具有良好的可接受性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b911/11128821/503830c76811/gr1.jpg

相似文献

1
IVsight as an Infusion Monitor for Patients Receiving Intravenous Therapy: An Exploratory, Unblinded, Single-Center Trial.
Curr Ther Res Clin Exp. 2024 Apr 1;100:100747. doi: 10.1016/j.curtheres.2024.100747. eCollection 2024.
3
IV DripAssist: An Innovative Way to Monitor Intravenous Infusions Away From an Outlet?
Mil Med. 2019 Mar 1;184(Suppl 1):322-325. doi: 10.1093/milmed/usy365.
4
Comparison of DripAssist to Traditional Method for Achieving Rate Infusions by U.S. Army Medics.
J Spec Oper Med. 2023 Oct 5;23(3):9-12. doi: 10.55460/DZ0I-FH6N.
5
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
10
Infusion techniques for peripheral arterial thrombolysis.
Cochrane Database Syst Rev. 2021 Nov 17;11(11):CD000985. doi: 10.1002/14651858.CD000985.pub3.

本文引用的文献

1
Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines.
Antimicrob Steward Healthc Epidemiol. 2021 Nov 3;1(1):e42. doi: 10.1017/ash.2021.213. eCollection 2021.
2
Cost minimization analysis of outpatient parenteral/oral antibiotic therapy at a trauma hospital: Public health system.
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1445-1450. doi: 10.1017/ice.2021.22. Epub 2021 Feb 23.
3
The REDCap consortium: Building an international community of software platform partners.
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
6
Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
J Antimicrob Chemother. 2009 Dec;64(6):1316-24. doi: 10.1093/jac/dkp343. Epub 2009 Sep 19.
7
Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients.
Am J Hypertens. 2007 Sep;20(9):942-8. doi: 10.1016/j.amjhyper.2007.03.020.
9
The U.S. home infusion market.
Am J Health Syst Pharm. 1998 Oct 1;55(19):2019-25. doi: 10.1093/ajhp/55.19.2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验